BRCA1 and ductal breast carcinoma in situ: If the scenario is true (that BRCA1/2 mutations are associated with good DCIS prognosis), it is possible that there are genetic and/or environmental modifiers predisposing DCIS in BRCA1/2 mutation carriers, which is associated with better survival [47].